The present invention is a chemical composition to detect and treat amyloid in a patient's brain or a retina, that include a nanoparticle or a Nano biopolymer delivery platform to deliver any combination of gadolinium, one or more contrast agents, one or more therapeutics and curcumin to mark said amyloid and a polymalic acid scaffold.